Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioTabs is a physician-led nutraceutical company that develops and markets evidence-based dietary supplements focused on cardiovascular health. Founded by cardiologists from the Saint Luke's Mid America Heart Institute, the company offers a portfolio of products including high-potency omega-3 fish oils, multivitamins, and specialized formulas for managing cholesterol and blood pressure. CardioTabs emphasizes clinical integrity and high-quality sourcing for its formulations, which are designed to support long-term heart health and preventative care. The company operates primarily through direct-to-consumer and healthcare provider channels. Its product line is formulated based on the latest cardiovascular research to ensure efficacy and safety for patients. The brand is widely recognized in the Midwest and among cardiology professionals for its commitment to heart-healthy lifestyle integration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CardioTabs.